| Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $35.77 | $7.2M |
| 2026-08-21 | Sukhatme Mayukh President & CIO | Sold | 317,655 | $36.86 | $11.7M |
| 2026-08-18 | Sukhatme Mayukh President & CIO | Sold | 664,826 | $36.34 | $24.2M |
| 2026-07-29 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $34.95 | $7.0M |
| 2026-06-30 | MANCHESTER KEITH S Director | Sold | 1,625,783 | $34.45 | $56.0M |
| 2026-06-30 | Gold Daniel Allen Director | Sold | 1,425,783 | $34.31 | $48.9M |
| 2026-06-30 | QVT Financial LP Insider | Sold | 1,425,783 | $34.31 | $48.9M |
| 2026-06-29 | Sukhatme Mayukh President & CIO | Sold | 1,000,000 | $34.10 | $34.1M |
| 2026-06-26 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $33.16 | $6.6M |
| 2026-05-22 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $30.27 | $6.1M |
| 2026-04-22 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $29.59 | $5.9M |
| 2026-04-20 | Gline Matthew CEO | Sold | 289,774 | $29.16 | $8.4M |
| 2026-03-30 | Fitzgerald Meghan Director | Sold | 70,000 | $27.45 | $1.9M |
| 2026-03-19 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $28.24 | $5.6M |
| 2026-03-18 | Epperly Melissa B, Director | Sold | 41,861 | $28.68 | $1.2M |
| 2026-02-23 | Torti Frank President and Vant Chair | Sold | 3,000,000 | $27.35 | $82.0M |
| 2026-02-18 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $26.49 | $5.3M |
| 2026-02-13 | MANCHESTER KEITH S Director | Sold | 1,225,784 | $26.64 | $32.7M |
| 2026-02-13 | Gold Daniel Allen Director | Sold | 1,225,784 | $26.64 | $32.7M |
| 2026-02-13 | QVT Financial LP Insider | Sold | 1,225,784 | $26.64 | $32.7M |
| 2026-02-11 | Sukhatme Mayukh President & CIO | Sold | 339,441 | $26.47 | $9.0M |
| 2026-01-14 | Venker Eric President & Immunovant CEO | Sold | 200,000 | $21.92 | $4.4M |
| 2025-12-31 | Sukhatme Mayukh President & CIO | Sold | 1,330,868 | $21.72 | $28.9M |
| 2025-12-29 | Pulik Richard CFO | Sold | 406,731 | $22.43 | $9.1M |
| 2025-12-29 | Venker Eric President & Immunovant CEO | Sold | 275,000 | $22.47 | $6.2M |
Showing the 25 most recent of 67 filings for ROIV in the last two years. The full history, the price chart with every buy and sell marked, and daily updates are in the members browser.
| Insider | Role | Buys | Total bought |
|---|---|---|---|
| Gline Matthew | CEO | 1 | $50k |
Every insider buy and sell for ROIV plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.
Open the browserFree sample